Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients

Journal of Diabetes and Its Complications
Monica VerdoiaNovara Atherosclerosis Study Group (NAS)

Abstract

Alterations of glucose homeostasis have been reported to occur even in non-diabetic patients, thus increasing the risk of cardiovascular events and worsening the outcome after an acute myocardial infarction (AMI). Still debated is the role of impaired glucose control in patients undergoing percutaneous coronary intervention (PCI), as hyperglycemia, represents an important pro-thrombotic stimulus, increasing platelet reactivity and potentially procedural complications. Therefore, the aim of our study was to assess the association between glycosylated hemoglobin and periprocedural myocardial infarction (PMI) in non-diabetic patients undergoing PCI. We included patients without history of diabetes undergoing elective PCI. PMI was defined as creatine kinase-MB increase by 3 times the upper limit normal or by 50% of an elevated baseline value, whereas periprocedural myonecrosis as Troponin I increase by 3× ULN or 50% of baseline. Our population is represented by 1199 patients, who were divided according to tertile values of glycosylated hemoglobin (HbA1c). Higher HbA1c was associated with ageing (p<0.001), hypertension (p=0.005), previous myocardial infarction (p=0.009), PCI (p<0.001) or CABG (p=0.001), treatment with diuretics (p<0...Continue Reading

References

Feb 14, 1998·Journal of the American College of Cardiology·R M CaliffE M Ohman
Aug 22, 2001·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·C CapozzoloM Chiariello
Jan 6, 2009·Diabetes Care·UNKNOWN American Diabetes Association
Jul 16, 2010·JACC. Cardiovascular Interventions·Nihar R Desai, Deepak L Bhatt
Aug 25, 2010·Clinical Cardiology·Elias B Hanna, Thomas A Hennebry
Feb 24, 2011·Circulation·José Luis Ferreiro, Dominick J Angiolillo
Jun 18, 2011·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Annunziata NuscaGermano Di Sciascio
Apr 25, 2012·Archives of Internal Medicine·Giuseppe De LucaUNKNOWN Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation
Aug 11, 2012·Journal of Atherosclerosis and Thrombosis·Nobutaka IkedaKaoru Sugi
Mar 20, 2013·The American Journal of Cardiology·Hitoshi TakanoUNKNOWN PRIMITIVE Study Investigators
Jul 23, 2013·The American Journal of Cardiology·Jaap W DeckersSjoerd T Nauta
Dec 4, 2013·Heart and Vessels·Monica VerdoiaUNKNOWN Novara Atherosclerosis Study Group (NAS)
Jan 1, 2014·The Review of Diabetic Studies : RDS·Sandra J Hamilton, Gerald F Watts
Jul 17, 2014·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Na LiYue-Jin Yang
Nov 27, 2014·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Cuneyt KocasMurat Ersanli

❮ Previous
Next ❯

Citations

Jun 27, 2020·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Mohamad SoudHector M Garcia-Garcia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Aging-Associated Metabolic Disorders

Age is associated with many metabolic disorders including cardiovascular diseases, type 2 diabetes, stroke and heart disease. The mediators in aging process have been suggested to play a part in the cellular processes responsible for these metabolic disorders. Here is the latest research on aging-associated metabolic disorders.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.